Opinion

Yan Leyfman

Jun 17, 2025, 02:22

Yan Leyfman: Keynote Address on PD-1/PD-L1 Inhibitors at the 2025 Frontiers in Cancer Immunotherapy Symposium

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“Great Keynote address highlighting the history of PD-1/PD-L1 inhibitors at the 2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium by Dr. Antoni Ribas of UCLA.”

Yan Leyfman

Antoni Ribas cancer Cancer Immunotherapy Symposium immunotherapy OncoDaily Oncology Yan Leyfman

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 2, 2025, 00:36

Elizabeth Smyth: Review on a Key Emerging Biomarker in Gastric and Gastroesophageal Cancer

Blog

Aug 2, 2025, 00:00

Maryam Lustberg: Discussing PCPs vs Oncologists

Blog

Aug 1, 2025, 19:24

Oliver Bogler: What Reviewers Hate to See

Science

Aug 1, 2025, 19:18

Wolfgang Miesbach: How Far Will AI Reach? Stanford's Virtual Lab's Breakthrough

Blog

Aug 1, 2025, 19:14

The Impact Your Support Makes in the Fight Against Cancer - NFCR

Blog

Aug 1, 2025, 19:10

YARN: An Ambitious, Bold and Promising EU-Funded Initiative - Youth Cancer Europe

Science

Aug 1, 2025, 19:04

Karen Knudsen: Science in Action - Men with Advanced Prostate Cancer Benefit

Positive

Aug 1, 2025, 18:57

Two Behaviour Change Campaigns Are the Finalists at 2025 Effie Awards - Cancer Institute NSW

Career

Aug 1, 2025, 18:52

Brian A. Walker Joins Sylvester Myeloma Institute - Sylvester Comprehensive Cancer Center

Blog

Aug 1, 2025, 18:42

Identifying and Preparing Eligible Patients for Screening with Confidence - ACS NLCRT

Insight

Aug 1, 2025, 18:37

Miguel Bronchud: SEOM Has Published the 2025 Medical Oncology Research Dossier in English

Blog

Aug 1, 2025, 18:32

Sharon Kapambwe: Representing WHO in Uzbekistan

Opinion

OncoDaily

Opinion

Yan Leyfman: Keynote Address on PD-1/PD-L1 Inhibitors at the 2025 Frontiers in Cancer Immunotherapy Symposium

“Great Keynote address highlighting the history of PD-1/PD-L1 inhibitors at the 2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium by Dr. Antoni Ribas of UCLA.”